These results show that the inhibition of circKsr2 may be a factor that can regulate a cognitive dysfunction such as AD by changing the levels of proteins such as p53, GFAP, and SYP in the hippocampus of APP/PS2 mice. Here, GFAP is linked to Alzheimer disease.